Allegion (ALLE) Stock Forecast, Price & News

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Allegion in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ALLE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ALLE, but not buy additional shares or sell existing shares.
View ALLE analyst ratings or view top-rated stocks.

9 brokers have issued twelve-month target prices for Allegion's stock. Their ALLE share price forecasts range from $110.00 to $128.00. On average, they predict the company's share price to reach $120.22 in the next year. This suggests a possible upside of 14.8% from the stock's current price.
View analysts price targets for ALLE or view top-rated stocks among Wall Street analysts.

Allegion's stock was trading at $105.26 at the beginning of the year. Since then, ALLE shares have decreased by 0.5% and is now trading at $104.74.
View the best growth stocks for 2023 here.

Allegion saw a increase in short interest in April. As of April 30th, there was short interest totaling 2,600,000 shares, an increase of 41.3% from the April 15th total of 1,840,000 shares. Based on an average daily trading volume, of 883,300 shares, the days-to-cover ratio is presently 2.9 days. Currently, 3.0% of the company's stock are sold short.
View Allegion's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 27th 2023.
View our ALLE earnings forecast.

Allegion plc (NYSE:ALLE) posted its quarterly earnings results on Wednesday, April, 26th. The scientific and technical instruments company reported $1.58 EPS for the quarter, beating the consensus estimate of $1.35 by $0.23. The scientific and technical instruments company had revenue of $923 million for the quarter, compared to the consensus estimate of $846.29 million. Allegion had a net margin of 14.07% and a trailing twelve-month return on equity of 61.34%. The company's quarterly revenue was up 27.6% on a year-over-year basis. During the same period in the previous year, the business posted $1.07 earnings per share.
Read the conference call transcript.

Allegion declared a quarterly dividend on Thursday, April 13th. Investors of record on Thursday, June 15th will be paid a dividend of $0.45 per share on Friday, June 30th. This represents a $1.80 dividend on an annualized basis and a yield of 1.72%. The ex-dividend date is Wednesday, June 14th.
Read our dividend analysis for ALLE.

ETFs with the largest weight of Allegion (NYSE:ALLE) stock in their portfolio include SPDR S&P Homebuilders ETF (XHB), Invesco S&P 500 Equal Weight Industrials ETF (RGI), Nuveen ESG Mid-Cap Growth ETF (NUMG), VanEck Morningstar ESG Moat ETF (MOTE), VanEck Morningstar Wide Moat ETF (MOAT), AdvisorShares Alpha DNA Equity Sentiment ETF (SENT), Natixis Vaughan Nelson Mid Cap ETF (VNMC) and First Trust Alerian US NextGen Infrastructure ETF (RBLD).

Allegion (NYSE:ALLE) pays an annual dividend of $1.80 per share and currently has a dividend yield of 1.68%. The company has been increasing its dividend for 9 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 32.55%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ALLE will have a dividend payout ratio of 25.86% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ALLE.

Allegion issued an update on its FY 2023 earnings guidance on Thursday, April, 27th. The company provided earnings per share guidance of $6.55-$6.75 for the period, compared to the consensus EPS estimate of $6.41. The company issued revenue guidance of $3.65 billion-$3.71 billion, compared to the consensus revenue estimate of $3.59 billion.

141 employees have rated Allegion Chief Executive Officer David (Dave) D. Petratis on Glassdoor.com. David (Dave) D. Petratis has an approval rating of 90% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Allegion investors own include Pfizer (PFE), AbbVie (ABBV), General Electric (GE), Johnson & Johnson (JNJ), Walmart (WMT), Citigroup (C), AT&T (T), UnitedHealth Group (UNH), Cisco Systems (CSCO) and Nucor (NUE).

Allegion trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALLE."

Allegion's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (9.81%), Boston Partners (4.58%), State Street Corp (4.20%), Kayne Anderson Rudnick Investment Management LLC (3.43%), Pictet Asset Management SA (3.28%) and AKO Capital LLP (2.63%). Insiders that own company stock include David D Petratis, David D Petratis, Douglas P Ranck, Jeffrey N Braun, John H Stone, Patrick S Shannon, Robert C Martens, Shelley A Meador, Timothy P Eckersley, Timothy P Eckersley and Tracy L Kemp.
View institutional ownership trends.

Shares of ALLE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ALLE stock can currently be purchased for approximately $104.74.

Allegion (NYSE:ALLE) has a market capitalization of $9.21 billion and generates $3.27 billion in revenue each year. The scientific and technical instruments company earns $458 million in net income (profit) each year or $5.53 on an earnings per share basis.

The company employs 12,300 workers across the globe.

Allegion's mailing address is BLOCK D IVEAGH COURT HARCOURT ROAD, DUBLIN L2, 46032. The official website for the company is www.allegion.com. The scientific and technical instruments company can be reached via phone at (531) 254-6200 or via email at michael.wagnes@allegion.com.